Johnson Fistel, PLLP Investigates Claims on Behalf of Alto Neuroscience, Inc. Long-Term Shareholders — Neutral
ANRO GlobeNewsWire — October 08, 2025SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of Alto Neuroscience, Inc. (NYSE: ANRO) shareholders against certain of its officers and directors who may have breached the fiduciary duties they owed to the Company.
Gen Digital: Trading At A Discount Despite Market Leadership And Expanded TAM — Positive
GEN Seeking Alpha — October 08, 2025Gen Digital (GEN) is rated a buy due to its transformation into an integrated digital life platform following the MoneyLion acquisition. GEN's entry into financial wellness doubles its total addressable market and creates a second long-term growth engine, leveraging its trusted cybersecurity brand. GEN's 500 million user base and strong cross-sell track record provide a structural advantage for scaling MoneyLion-powered offerings efficiently.
Is the Options Market Predicting a Spike in Ameren Stock? — Neutral
AEE Zacks Investment Research — October 08, 2025Investors need to pay close attention to AEE stock based on the movements in the options market lately.
Shell Expects Higher Q3 LNG Output and Stronger Gas Trading — Positive
SHEL Zacks Investment Research — October 08, 2025SHEL's third-quarter 2025 update highlights LNG growth, upstream gains, refining strength and ongoing RES volatility amid Brazil impact and global energy market shifts.
Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings — Positive
PFE Zacks Investment Research — October 08, 2025Pfizer's oncology strength, powered by Seagen's ADCs and key drugs like Xtandi and Lorbrena, is likely to be in focus ahead of Q3 earnings.
Recent Price Trend in FitLife Brands (FTLF) is Your Friend, Here's Why — Positive
FTLF Zacks Investment Research — October 08, 2025FitLife Brands (FTLF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
GS WFC Zacks Investment Research — October 08, 2025Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Jackson Financial (JXN) Is Attractively Priced Despite Fast-paced Momentum — Positive
JXN Zacks Investment Research — October 08, 2025Jackson Financial (JXN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Discretionary Names — Positive
CCL RL Zacks Investment Research — October 08, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Despite Fast-paced Momentum, Ford Motor (F) Is Still a Bargain Stock — Positive
F Zacks Investment Research — October 08, 2025Ford Motor (F) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now — Positive
MPC WES Zacks Investment Research — October 08, 2025Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Utilities Stocks Now — Positive
DUK NRG Zacks Investment Research — October 08, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now — Positive
HSY MNST Zacks Investment Research — October 08, 2025Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
GILD JNJ Zacks Investment Research — October 08, 2025Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
EXAS INCY Zacks Investment Research — October 08, 2025Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now — Positive
FSLR SHEL Zacks Investment Research — October 08, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Momentum Meets Value: Oracle Stock's Next Leg Could Be Higher — Positive
ORCL Forbes — October 08, 2025Oracle (ORCL) stock could be an excellent option to capitalize on the momentum. Why? This is due to its strong margins, low-debt capital structure, fair valuation, and positive momentum.
LNTH DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus — Neutral
LNTH GlobeNewsWire — October 08, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
Aehr Test Systems: Post-Earnings Selloff Overlooks Its Expanding AI Opportunity — Neutral
AEHR Seeking Alpha — October 08, 2025I believe Aehr Test Systems' post-earnings selloff is an overreaction as weak earnings were expected due to the ongoing broader semiconductor industry weakness. The post-earnings selloff overlooks Aehr's potential to displace inefficient burn-in processes performed by ASIC suppliers with its FOX systems and the high-margin WaferPaks. Aehr's ongoing paid evaluation with a leading AI processor supplier could be a prelude to significant production orders for FOX-XP systems and WaferPaks in FY 2027.
3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal — Positive
BAYRY JNJ NVS Zacks Investment Research — October 08, 2025Pfizer's landmark pricing deal with Trump sparks a pharma rally as J&J, Bayer and Novartis emerge as strong contenders for inclusion in one's portfolio.
